Proteinuria of nonautoimmune origin in wild-type FVB/NJ mice

Comparative Medicine

Volumn 57, Issue 3, 2007, Pages 255-266

  Maier, Shannon M ^a,b   Gross, Joanne K ^a   Hamlin, Kassie L ^a   Maier, Julie L ^a   Workman, Jennifer L ^a   Kim Howard, Xana R ^a   Schoeb, Trenton R ^c   Farris, A Darise ^a,b,c  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; FEMALE; HYPERCHOLESTEROLEMIA; MALE; MICROSCOPY; MINIMAL CHANGE GLOMERULONEPHRITIS; MOUSE; MOUSE STRAIN; NEPHROTIC SYNDROME; NONHUMAN; PODOCYTE; PROTEINURIA; TH2 CELL; WILD TYPE;

ALBUMINURIA; ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNITY; CHOLESTEROL; CREATININE; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULAR BASEMENT MEMBRANE; IMMUNOGLOBULIN G; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; NEPHROSIS, LIPOID; PODOCYTES; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 34250816305     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Auerbach AB, Norinsky R, Ho W, Losos K, Guo Q, Chatterjee S, Joyner AL. 2003. Strain-dependent differences in the efficiency of transgenic mouse production. Transgenic Res 12:59-69.
2. Barisoni L, Mundel P. 2003. Podocyte biology and the emerging understanding of podocyte diseases. Am J Nephrol 23:353-360.
3. Batlle-Gualda E, Martinez AC, Guerra RA, Pascual E. 1997. Urinary albumin excretion in patients with systemic lupus erythematosus without renal disease. Ann Rheum Dis 56:386-389.
4. Bickerstaff MC, Botto M, Hutchinson WL, Herbert J, Tennent GA, Bybee A, Mitchell DA, Cook HT, Butler PJ, Walport MJ, Pepys MB. 1999. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med 5:694-697.
5. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. 1999. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 19:1992-1997.
6. Botto M. 1998. C1q knock-out mice for the study of complement deficiency in autoimmune disease. Exp Clin Immunogenet 15:231-234.
7. Bygrave AE, Rose KL, Cortes-Hernandez J, Warren J, Rigby RJ, Cook HT, Walport MJ, Vyse TJ, Botto M. 2004. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol 2:E243.
8. Chen A, Sheu LF, Chou WY, Ho YS, Lin YF, Lin FG, Lee WH. 1998. Involvement of immunopathogenic mechanisms in a spontaneously occurring glomerulopathy in mice. Nephron 78:63-72.
9. Chen A, Sheu LF, Ho YS, Lin YF, Chou WY, Chou TC, Lee WH. 1998. Experimental focal segmental glomerulosclerosis in mice. Nephron 78:440-452.
10. Cverna F, Hamlin CR. 1986. Calculating unknown concentrations from nonlinear standard curves. Clin Chem 32:1307-1310.
11. Davies I, Fotheringham AP, Faragher BE. 1989. Age-associated changes in the kidney of the laboratory mouse. Age Ageing 18:127-133.
12. Gamble J, Bancroft M. 2001. Theory and practice of histological techniques. New York: Churchill Livingstone.
13. Gekle M. 1998. Renal proximal tubular albumin reabsorption: daily prevention of albuminuria. News Physiol Sci 13:5-11.
14. Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, Yunis W, Xu S, Eckman C, Younkin S, Price D, Iadecola C, Clark HB, Carlson G. 1995. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15:1203-1218.
15. Hutchison AS, O'Reilly DS, MacCuish AC. 1988. Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria. Clin Chem 34:2019-2021.
16. Ishimori N, Li R, Kelmenson PM, Korstanje R, Walsh KA, Churchill GA, Forsman-Semb K, Paigen B. 2004. Quantitative trait loci analysis for plasma HDL-cholesterol concentrations and atherosclerosis susceptibility between inbred mouse strains C57BL/6J and 129S1/ SvImJ. Arterioscler Thromb Vasc Biol 24:161-166.
17. The Jackson Laboratory [Internet]. 2006. Phenome database [cited 1 April 2006]. Available at http://phenome.jax.org/pub-cgi/phenome/mpdcgi?rtn= docs/home].
18. Joles JA, Kunter U, Janssen U, Kriz W, Rabelink TJ, Koomans HA, Floege J. 2000. Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol 11:669-683.
19. Ke L, Yuan YS. 1989. Determination of estriol and creatinine in urine by high performance liquid chromatography. Biomed Chromatogr 3:196-198.
20. Keane WF. 2000. The role of lipids in renal disease: future challenges. Kidney Int Suppl 75:S27-31.
21. Keane WF, Eknoyan G. 1999. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis 33:1004-1010.
22. Keane WF, Kasiske BL, O'Donnell MP. 1987. The role of lipids in progressive glomerular disease. Adv Exp Med Biol 223:81-87.
23. Lahdenkari AT, Lounatmaa K, Patrakka J, Holmberg C, Wartiovaara J, Kestila M, Koskimies O, Jalanko H. 2004. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria. J Am Soc Nephrol 15:2611-2618.
24. Lowenborg EK, Berg UB. 1999. Influence of serum albumin on renal function in nephrotic syndrome. Pediatr Nephrol 13:19-25.
25. Macconi D, Bonomelli M, Benigni A, Plati T, Sangalli F, Longaretti L, Conti S, Kawachi H, Hill P, Remuzzi G, Remuzzi A. 2006. Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury. Am J Pathol 168:42-54.
26. Mathieson PW. 2004. The cellular basis of albuminuria. Clin Sci (Lond) 107:533-538.
27. Medical College of Georgia [Internet]. Animal models of diabetic complication consortium [cited 14 April 2006] Available at http:// www.amdcc.org/.
28. Meir KS, Leitersdorf E. 2004. Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 24:1006-1014.
29. Min S, Yisheng Y, Lu Y. 1992. Determination of urinary 3-methylhistidine by high-performance liquid chromatography with o-phthaldialdehyde precolumn derivatization. J Chromatogr 581:272-276.
30. Mundel P, Reiser J. 1997. New aspects of podocyte cell biology. Kidney Blood Press Res 20:173-176.
31. Mundel P, Schwarz K, Reiser J. 2001. Podocyte biology: a footstep further. Adv Nephrol Necker Hosp 31:235-241.
32. Mundel P, Shankland SJ. 2002. Podocyte biology and response to injury. J Am Soc Nephrol 13:3005-3015.
33. Mutlu EA, Keshavarzian A, Mutlu GM. 2006. Hyperalbuminemia and elevated transaminases associated with high-protein diet. Scandinavian journal of gastroenterology 41:759-760.
34. Myers BD, Okarma TB, Friedman S, Bridges C, Ross J, Asseff S, Deen WM. 1982. Mechanisms of proteinuria in human glomerulonephritis. J Clin Invest 70:732-746.
35. Obata Y, Tanaka T, Stockert E, Good RA. 1979. Autoimmune and lymphoproliferative disease in (B6-GIX+ X 129)F1 mice: relation to naturally occurring antibodies against murine leukemia virus-related cell surface antigens. Proc Natl Acad Sci U S A 76:5289-5293.
36. Osman GE, Hannibal MC, Anderson JP, Lasky SR, Ladiges WC, Hood L. 1999. FVB/N (H2(q)) mouse is resistant to arthritis induction and exhibits a genomic deletion of T-cell receptor V beta gene segments. Immunogenetics 49:851-859.
37. Patrakka J, Lahdenkari AT, Koskimies O, Holmberg C, Wartiovaara J, Jalanko H. 2002. The number of podocyte slit diaphragms is decreased in minimal change nephrotic syndrome. Pediatr Res 52:349-355.
38. Poskitt PK, Poskitt TR. 1982. Absence of circulating IgC immune Complexes in C57BI/6 mice with age-associated renal IgG deposits. Immunol Commun 11:97-104.
39. Reichlin M, Fesmire J, Quintero-Del-Rio AI, Wolfson-Reichlin M. 2002. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus. Arthritis Rheum 46:2957-2963.
40. Remuzzi A, Puntorieri S, Alfano M, Macconi D, Abbate M, Bertani T, Remuzzi G. 1992. Pathophysiologic implications of proteinuria in a rat model of progressive glomerular injury. Lab Invest 67:572-579.
41. Roselli S, Heidet L, Sich M, Henger A, Kretzler M, Gubler MC, Antignac C. 2004. Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol 24:550-560.
42. Santiago-Raber ML, Lawson BR, Dummer W, Barnhouse M, Koundouris S, Wilson CB, Kono DH, Theofilopoulos AN. 2001. Role of cyclin kinase inhibitor p21 in systemic autoimmunity. J Immunol 167:4067-4074.
43. Taketo M, Schroeder AC, Mobraaten LE, Gunning KB, Hanten G, Fox RR, Roderick TH, Stewart CL, Lilly F, Hansen CT. 1991. FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc Natl Acad Sci U S A 88:2065-2069.
44. Tsikas D, Wolf A, Frolich JC. 2004. Simplified HPLC method for urinary and circulating creatinine. Clin Chem 50:201-203.
45. Wang Z, Jiang T, Li J, Proctor C, McManaman JL, Lucia S, Chua S, Levi M. 2005. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes 54:2328-2335.
46. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M. 2004. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65:521-530.
47. Wharram BL, Goyal M, Gillespie PJ, Wiggins JE, Kershaw DB, Holzman LB, Dysko RC, Saunders TL, Samuelson LC, Wiggins RC. 2000. Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate. J Clin Invest 106:1281-1290.
48. Whitehead GS, Walker JK, Berman KG, Foster WM, Schwartz DA. 2003. Allergen-induced airway disease is mouse strain dependent. Am J Physiol Lung Cell Mol Physiol 285:L32-42.
49. Widstam-Attorps U, Berg U, Bohman SO, Lefvert AK. 1992. Proteinuria and renal function in relation to renal morphology. A clinicopathological study of IgA nephropathy at the time of kidney biopsy. Clin Nephrol 38:245-253.
50. Wingo CS, Clapp WL. 2000. Proteinuria: potential causes and approach to evaluation. Am J Med Sci 320:188-194.
51. Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE, Wareham NJ. 2004. A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population: the EPIC-Norfolk study. Am J Epidemiol 159:284-293.
52. Zheng F, Plati AR, Potier M, Schulman Y, Berho M, Banerjee A, Leclercq B, Zisman A, Striker LJ, Striker GE. 2003. Resistance to glomerulosclerosis in B6 mice disappears after menopause. Am J Pathol 162:1339-1348.